Screening for lung cancer can save lives, and there's an urgent need for more screening of people of color. That's one of the takeaways from the newly released "State of Lung Cancer" report from the American Lung Association.
Nov 17, 2023
0
0
Diagnosing early-stage lung cancer with low-dose computed tomography (CT) screening drastically improves its cure rate measured over a 20-year period, according to a large-scale international study by Mount Sinai researchers ...
Nov 7, 2023
0
1
Patients with cancer whose oncologists receive payments from industry appear more likely to receive some non-recommended and low-value treatments, finds a US study published by The BMJ today.
Oct 25, 2023
0
0
The lung is one of the tissues most sensitive to radiation in the human body. People exposed to high radiation doses following nuclear incidents develop radiation-induced lung injury (RILI), which affects the function of ...
Oct 17, 2023
0
22
Over two million years of life are lost to cancer in the UK every year, according to new research published today in the British Journal of Cancer.
Oct 11, 2023
0
0
Currently, researchers from different institutions in the world are testing a drug against obesity and diabetes, and now a Danish led research team reports that the same substance has had a beneficial effect on mice with ...
Oct 11, 2023
0
1
A new editorial paper titled "Promising trends in lung cancer care, but are we overlooking the majority?" has been published in Aging.
Sep 27, 2023
0
0
Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine found an association between "social determinants of health" and outcomes and survival in patients undergoing surgery ...
Sep 24, 2023
1
7
Intensity-modulated radiation therapy (IMRT) should be the preferred choice when treating patients with locally advanced non-small cell lung cancer (NSCLC), as it reduces radiation exposure to the heart and lungs, according ...
Sep 11, 2023
0
8
The oral, selective KRAS G12C inhibitor KRAS-G12C inhibitor adagrasib demonstrated durable clinical activity, with a median overall survival of 14.1 months and approximately one in three patients alive at two years, according ...
Sep 9, 2023
0
18
